Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a ...

On Tuesday, Cathie Wood -led Ark Invest made significant trades involving Tempus AI Inc. TEM , Advanced Micro Devices Inc.

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S. Haque, Ph.D., to the role of chief ...

S4A IT Solutions (S4A) proudly announces its recent certification from Neptune Software, a global leader in low-code/no-code application development platforms. This significant achievement underscores ...

Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times for advanced therapies.

Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have received an average recommendation of “Buy” from the seven ...

Shares of enGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) have received a consensus rating of “Buy” from the ten ...

Recursion announced that Namandje Bumpus, Ph.D, and Elaine Sun have been appointed to Recursion’s Board of Directors, effective as of March ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.